Skip to content

Application of noninvasive lung fluid measurement in patients with heart failure

Application of noninvasive lung fluid measurement in patients with heart failure

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094501
Enrollment
Unknown
Registered
2024-12-24
Start date
2024-12-31
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Interventions

Sponsors

Fuwai Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Hospitalized patients with heart failure aged > 18 years; Voluntarily participate in this study; Diagnosis of heart failure in accordance with National Heart Failure Guidelines 2023

Exclusion criteria

Exclusion criteria: 1. Assess physical conditions unsuitable for wearing a ReDS non-invasive pulmonometer, including but not limited to: BMI39kg/m2, or height 195cm, or flail chest, etc. (ReDS should be tested for patients with a BMI of 20-22kg/m^2, and patients with a height of 150-155cm to ensure physical fitness); 2. Have a history of heart transplantation or left ventricular assist device implantation, and are still implanted; 3. Combined pulmonary disease, such as active pneumonia, acute pulmonary embolism, or history of acute pulmonary embolism within the past 6 months; 4. Severe pulmonary hypertension caused by non-left heart disease (pulmonary systolic blood pressure =70mmHg as measured by echocardiography); 5. Simple right heart failure; 6. Patients who have undergone open-heart surgery or other operations or procedures during or within one year of their intended hospitalization that affect the wearing of ReDS; 7. Pulmonary tissue insufficiency due to various reasons such as surgery and trauma; 8. Patients with severe renal insufficiency (eGFR<20ml/min/1.73m^2) or dialysis; 9. Complicated with malignant tumor or other serious diseases, and the expected survival time is less than 1 year; 10. Women in pregnancy, pregnancy is defined as the state of a woman after pregnancy until termination of pregnancy; 11. Failure to follow study instructions or to follow examination, evaluation and follow-up procedures; 12. Any other medical condition that the investigator believes may put the patient at risk or affect the results of the study, or that the investigator believes there is a medical condition that is not appropriate for the study; 13. Participating in other intervention studies (including patients during washout)

Design outcomes

Secondary

MeasureTime frame
Chest X-ray;NT-proBNP;PCWP;HCT;Urine specific gravity;IVCD;Ultrasound extravascular lung fluid;CVP;

Primary

MeasureTime frame
Noninvasive lung fluid value ReDS;

Countries

China

Contacts

Public ContactYuhui Zhang

Fuwai Hospital, Chinese Academy of Medical Sciences

yuhuizhangjoy@163.com+86 159 0131 4243

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026